Gestational diabetes mellitus: Get, set, go From diabetes capital of the world to diabetes care capital of the world
- PMID: 21897891
- PMCID: PMC3156534
- DOI: 10.4103/2230-8210.83398
Gestational diabetes mellitus: Get, set, go From diabetes capital of the world to diabetes care capital of the world
Abstract
Screening and diagnosis for gestational diabetes mellitus (GDM) as well as interventions for its management evoke considerable controversy. There are different types of screening methods: universal or risk-based, one step or two step. Different thresholds for diagnosis of GDM have been in vogue. Previous definition and diagnostic criteria had no place for diagnosis of overt diabetes in pregnancy. Following Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study and International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommendations, new screening and diagnostic criteria around the world seem to be gaining consensus. The present recommendation given by IADPSG for screening and diagnosis of diabetes mellitus in pregnancy has two discrete phases. The first is detection of women with overt diabetes not previously diagnosed or treated outside of pregnancy. Universal early testing in populations is recommended at the first prenatal visit. The second phase is a 75-g OGTT at 24-28 week gestation in all women not previously found to have overt diabetes or GDM. ACHOIS and MFMU Network trails have proven benefit in treating hyperglycemias less than what is diagnostic for diabetes. DIPSI has shown the alternative way for resource-challenged communities. Efforts from all stake holders with interest in GDM are required to make the diabetes capital of the world into the diabetes care capital of the world.
Keywords: Diabetes in Pregnancy Study Group India; Hyperglycemia and Adverse Pregnancy Outcomes study; International Association of Diabetes and Pregnancy Study Groups; gestational diabetes mellitus; guidelines; screening.
Conflict of interest statement
References
-
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53. - PubMed
-
- Sicree R, Shaw J, Zimmet P. Diabetes Atlas International Diabetes Federation. 4th ed. Belgium: International Diabetes Federation; 2009. The Global Burden: Diabetes and impaired glucose tolerance; pp. 1–105.
-
- American Diabetes Association. Clinical practice recommendations 2001: Gestational Diabetes Mellitus. Diabetes Care. 2001;24(Suppl 1):S77–9. - PubMed
-
- Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(Suppl 2):B161–7. - PubMed
-
- O’Sullivan JB, Mahan CM. Criteria for oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278–85. - PubMed
